Cited by 656Hypothalamic control of reproductive hormonesNeuropeptides and Animal PhysiologyRegulation of Appetite and Obesity

Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males

Dhillo, Waljit S., Chaudhri, Owais B., Patterson, Michael, Thompson, Emily L., Murphy, Kevin G., Badman, Michael K., McGowan, Barbara M., Amber, Vian +3 more·2005·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Mutation of the G protein-coupled receptor 54 is associated with a failure of reproductive function. The endogenous neuropeptide agonist for G protein-coupled receptor 54, kisspeptin, potently stimulates the hypothalamic-pituitary-gonadal axis in rodents and primates. OBJECTIVE: The present study was designed to determine the effects of elevating circulating kisspeptin levels on LH, FSH, and testosterone in male volunteers. DESIGN: This was a double-blind, placebo-controlled, crossover study. SETTING: This was a hospital-based study. PARTICIPANTS: Male volunteers (n = 6) were recruited. INTERVENTIONS: Each volunteer received a 90-min i.v. infusion of kisspeptin-54 (4 pmol/kg x min) and a control infusion of saline (0.9%) in random order. MAIN OUTCOME MEASURE: Plasma LH, FSH, and testosterone concentrations were measured. RESULTS: Kisspeptin-54 infusion significantly increased plasma LH, FSH, and testosterone concentrations compared with saline infusion (mean 90-min LH: kisspeptin, 10.8 +/- 1.5 vs. saline, 4.2 +/- 0.5 U/liter, P < 0.001; mean 90-min FSH: kisspeptin, 3.9 +/- 0.7 vs. saline, 3.2 +/- 0.6 U/liter, P < 0.001; mean 180-min testosterone: kisspeptin, 24.9 +/- 1.7 vs. saline, 21.7 +/- 2.2 nmol/liter, P < 0.001). The plasma half-life of kisspeptin-54 was calculated to be 27.6 +/- 1.1 min. The mean metabolic clearance rate was 3.2 +/- 0.2 ml/kg x min, and the volume of distribution was 128.9 +/- 12.5 ml/kg. CONCLUSION: Elevation of plasma concentrations of kisspeptin in human males significantly increases circulating LH, FSH, and testosterone levels. Kisspeptin infusion provides a novel mechanism for hypothalamic-pituitary-gonadal axis manipulation in disorders of the reproductive system.

Integrity signals

Registry

Crossref · 10.1210/jc.2005-1468

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Administration of kisspeptin results in increases in plasma LH concentrations in healthy men, and in women kisspeptin also induces LH release, although the response varies across the menstrual cycle.

    “Administration of kisspeptin results in increases in plasma LH concentrations in healthy men,54,55 and in women kisspeptin also induces LH release, although the response varies across the menstrual cycle.56”

    From Pubertal development and regulation (2016) · cites this paper as [54]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dhillo, W. S., Chaudhri, O. B., Patterson, M., Thompson, E. L., Murphy, K. G., Badman, M. K., McGowan, B. M., Amber, V., Patel, S., Ghatei, M. A., & Bloom, S. R.
Affiliations
  • Imperial College London (GB)
  • Hammersmith Hospital (GB)
Corresponding author
Bloom, Stephen R.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2005-12
Volume
90
Issue
12
Pages
6609-6615
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2120568375
Cited by
656
References
33
Citations by year
2026: 10 · 2025: 16 · 2024: 15 · 2023: 28 · 2022: 28 · 2021: 35 · 2020: 27 · 2019: 31 · 2018: 36 · 2017: 28 · 2016: 35 · 2015: 41 · 2014: 38 · 2013: 36 · 2012: 47
FWCI
34.49
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • GlaxoSmithKline
  • Wellcome Trust
  • Imperial College London
  • Directorate for Biological Sciences
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
kisspeptin-54, kisspeptin, hypothalamic-pituitary-gonadal axis, luteinizing hormone, follicle-stimulating hormone, testosterone, male reproductive function
MeSH terms
Receptors, Kisspeptin-1, Adult, Dose-Response Relationship, Drug, Follicle Stimulating Hormone, Half-Life, Humans, Hypothalamo-Hypophyseal System, Infusions, Intravenous, Luteinizing Hormone, Male, Osmolar Concentration, Pituitary-Adrenal System, Proteins, Testosterone, Time Factors, Receptors, Neuropeptide, Cross-Over Studies, Tumor Suppressor Proteins, Receptors, G-Protein-Coupled, Kisspeptins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review